These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6834573)

  • 1. Preliminary results of glycosminoglycans excretion in normal and stone forming subjects: relationship with uric acid excretion.
    Caudarella R; Stefani F; Rizzoli E; Malavolta N; D'Antuono G
    J Urol; 1983 Mar; 129(3):665-7. PubMed ID: 6834573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid and its relationship with glycosaminoglycans in normal and stone-former subjects.
    Conte A; Roca P; Genestar C; Grases F
    Nephron; 1989; 52(2):162-5. PubMed ID: 2500615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary glycosaminoglycan excretion in normal and stone-forming subjects: significant disturbance in recurrent stone formers.
    Nikkilä MT
    Urol Int; 1989; 44(3):157-9. PubMed ID: 2749930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dietary control of urinary uric acid excretion in calcium oxalate stone formers and non-stone-forming controls.
    Pais VM; Holmes RP; Assimos DG
    J Endourol; 2007 Feb; 21(2):232-5. PubMed ID: 17338626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of the 24-hour urine analysis in the assessment of stone-formers attending a general hospital outpatient clinic.
    Ryall RL; Marshall VR
    Br J Urol; 1983 Feb; 55(1):1-5. PubMed ID: 6824849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between urinary inhibitory activity and endogenous concentrations of glycosaminoglycans and uric acid: comparison of urines from stone-formers and normal subjects.
    Ryall RL; Marshall VR
    Clin Chim Acta; 1984 Aug; 141(2-3):197-204. PubMed ID: 6488555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral purine loading test for latent metabolic disorders of uric acid in patients with calcium containing upper urinary calculi].
    Yoneda K
    Hinyokika Kiyo; 1992 Aug; 38(8):877-84. PubMed ID: 1414737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of diclofenac sodium on urinary concentration of calcium, uric acid and glycosaminoglycans in traumatic paraplegics.
    Sharma S; Vaidyanathan S; Thind SK; Nath R; Sankaranarayanan A
    Br J Urol; 1991 Sep; 68(3):240-2. PubMed ID: 1913063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of GAGS on 24-hour and 2-hour urines from calcium oxalate stone formers and healthy subjects.
    Gianotti M; Genestar C; Palou A; Pons A; Conte A; Grases F
    Int Urol Nephrol; 1989; 21(3):281-8. PubMed ID: 2807779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary glycosaminoglycans as risk factors for uric acid nephrolithiasis: case control study in a Sardinian genetic isolate.
    Ombra MN; Casula S; Biino G; Maestrale G; Cardia F; Melis P; Pirastu M
    Urology; 2003 Sep; 62(3):416-20. PubMed ID: 12946738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosaminoglycans in urolithiasis.
    Nesse A; Garbossa G; Romero MC; Bogado CE; Zanchetta JR
    Nephron; 1992; 62(1):36-9. PubMed ID: 1436289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evaluation of risk factors in male stone-formers attending a general hospital out-patient clinic.
    Ryall RL; Darroch JN; Marshall VR
    Br J Urol; 1984 Apr; 56(2):116-21. PubMed ID: 6498429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The excretion of glycosaminoglycans in the urine of calcium-oxalate-stone patients and healthy persons.
    Hesse A; Wuzel H; Vahlensieck W
    Urol Int; 1986; 41(2):81-7. PubMed ID: 3727195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of uricine.
    Pinto B; Rocha E
    Invest Urol; 1977 Sep; 15(2):155-7. PubMed ID: 20424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric acid disorders in patients with calcium stones.
    Hodgkinson A
    Br J Urol; 1976 Feb; 48(1):1-5. PubMed ID: 1268456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of glycosaminoglycans in normal and stone forming subjects.
    Michelacci YM; Glashan RQ; Schor N
    Kidney Int; 1989 Dec; 36(6):1022-8. PubMed ID: 2601252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of 24-hour urinary excretion of glycosaminoglycans by renal stone formers and healthy adults.
    Sidhu H; Hemal AK; Thind SK; Nath R; Vaidyanathan S
    Eur Urol; 1989; 16(1):45-7. PubMed ID: 2714317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.